Document ID: chunk:federal_register_of_legislation:F2022L01381:reg:8:p2
Version: federal_register_of_legislation:F2022L01381
Segment Type: reg
Provision Reference: reg 8 (pt 2/2)
Character Range: 6145–8112

cytomegalovirus infection of new onset within the 30 days before the clinical onset of portal vein thrombosis;
(13)      having infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within the 2 months before the clinical onset of portal vein thrombosis;
Note: SARS-CoV-2 is the virus which causes coronavirus disease 2019 (COVID-19).
(14)      having chronic infection with hepatitis B virus at the time of the clinical onset of portal vein thrombosis;
Note: chronic infection with hepatitis B virus is defined in the Schedule 1 – Dictionary.
(15)      having chronic infection with hepatitis C virus at the time of the clinical onset of portal vein thrombosis;
Note: chronic infection with hepatitis C virus is defined in the Schedule 1 – Dictionary.
(16)      having foreign body penetration or occlusion of the portal vein, splenic vein or superior mesenteric vein within the 30 days before the clinical onset of portal vein thrombosis;
Note: Examples of circumstances where foreign body penetration or occlusion of the portal vein, splenic vein or superior mesenteric vein may occur include the ingestion of fish bones, toothpicks or metal wires and the migration of a pancreatic stent.
(17)      having blunt trauma to the abdomen within the 30 days before the clinical onset of portal vein thrombosis;
Note: Circumstances in which blunt trauma to the abdomen can occur include falls, motor vehicle accidents and a blow to the abdomen.
(18)      undertaking underwater diving with compressed air within the 24 hours before the clinical onset of portal vein thrombosis;
(19)      being obese at the time of the clinical onset of portal vein thrombosis;
Note: being obese is defined in the Schedule 1 - Dictionary.
(20)      undergoing a liver transplant or stem cell transplant within the 2 months before the clinical onset of portal vein thrombosis;
(21)      inability to obtain appropriate clinical management for portal vein thrombosis.